Children with cystic fibrosis who are taking ivacaftor (Kalydeco) may be at potential risk for cataracts, according to an FDA notification.
FDA approved linaclotide (Linzess, Ironwood Pharmaceuticals and Forest) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation in adults.
At its Pharmacy and Technology Conference, the National Association of Chain Drug Stores presented Doug Long with the prestigious Harold W. Pratt Award.
FDA has approved the supplemental New Drug Application for tapentadol extended-release tablets (Nucynta ER, Janssen), an oral analgesic taken twice daily, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
In a letter to Pennsylvania state lawmakers, the National Community Pharmacists Association urged the leaders to support legislation concerning pharmacy audits.
FDA has approved Watson's lidocaine topical patch 5%, the first generic version of (Endo) for the relief of pain associated with post-herpetic neuralgia.
FDA has approved buprenorphine and naloxone (Suboxone, Reckitt Benckiser Pharmaceuticals) sublingual film in the 4-mg and 12-mg strengths for the maintenance treatment of dependence on prescription opioid painkillers and heroin.
FDA approved Mylan Pharmaceutical's 15-mg, 30-mg, and 45-mg pioglitazone hydrochloride tablets, the first generic version of Actos (Takeda), along with diet and exercise to improve blood glucose control in adults with type 2 diabetes.
Seattle-based Bartell Drugs and the Space Needle are set to launch back-to-school promotion.
At the urging of the Texas Legislature, the Texas Department of Public Safety developed the Prescription Access in Texas program, which provides controlled substances dispensing history to authorized healthcare and law enforcement professionals.